(Adds details on other companies targeted)
BERLIN, Jan 14 (Reuters) - Clariant said it would defend itself against a claim from German rival BASF
seeking 1.4 billion euros ($1.4 billion) in damages from a group of companies, including Clariant, fined by the EU for colluding in the purchase of ethylene before 2020.
Clariant was served with a claim targeting four companies on Jan. 9, the Swiss chemicals group said in a statement issued late on Monday.
The European Commission in 2020 fined Clariant, Mexico's Orbia and U.S. group Celanese a total of 260 million euros for colluding to keep the price of ethylene purchases low, breaching European Union antitrust rules.
The EU Commission said at the time that Westlake also took part in the purchasing cartel but was spared a fine because it revealed the activities to the Commission.
Clariant said it had evidence that the conduct of the parties did not have any effect on the market.
"Clariant firmly rejects the allegation and will adamantly defend its position in the proceedings," it added.
BASF did not respond to an emailed request for comment.
A Clariant spokesperson confirmed that BASF's claims were directed at the four companies and that there would have to be a separate decision on how any compensation payment is to be distributed among them once there is a legally valid verdict.
The other companies did not immediately respond to requests for comment.
BASF's claim was filed with a Munich court, alleging damages from infringements of EU competition rules in the 2020 case, according to Clariant.
Clariant shares were down 1.5% as of 1300 GMT.
The EU Commission also said in 2020 that the four companies acknowledged their involvement in the cartel and agreed to settle the case.
($1 = 0.9747 euros)
(Writing by Rachel More and Ludwig Burger; editing by Jason Neely, Miranda Murray and Emelia Sithole-Matarise)
((rachel.more@thomsonreuters.com;))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。